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Type 2 diabetes mellitus (T2DM) is a major and fast growing public health problem. Although obesity is considered
to be the main driver of the pandemic of T2DM, a possible contribution of some environmental contaminants, of
which persistent organic pollutants (POPs) form a particular class, has been suggested. POPs are organic
compounds that are resistant to environmental degradation through chemical, biological, and photolytic processes
which enable them to persist in the environment, to be capable of long-range transport, bio accumulate in human
and animal tissue, bio accumulate in food chains, and to have potential significant impacts on human health and
the environment. Several epidemiological studies have reported an association between persistent organic pollutants
and diabetes risk. These findings have been replicated in experimental studies both in human (in-vitro) and animals
(in-vivo and in-vitro), and patho-physiological derangements through which these pollutants exercise their harmful
effect on diabetes risk postulated. This review summarizes available studies, emphasises on limitations so as to enable
subsequent studies to be centralized on possible pathways and bring out clearly the role of POPs on diabetes risk.
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Type 2 diabetes (T2DM), the most common form of dia-
betes mellitus, is a complex condition resulting from the
interaction between environmental and genetic factors.
The global population of adults with diabetes was esti-
mated to be 382 million (8 · 3%) in 2013 of which 175
million of cases are currently undiagnosed and this fig-
ure is predicted to rise to around 592 million (10.1%) by
2035 (International Diabetes Federation [1]).The major-
ity of people with diabetes are aged between 40 and
59 years, and 80% of them live in low- and middle-
income countries (IDF, International Diabetes Federation
[1]). Higher-than-optimal weight resulting from the
combined effects of unhealthy diets and decreased phys-
ical activity is a major driver of the ongoing pandemic of
T2DM. Mounting evidences have also suggested the
contribution of some environmental contaminants to the
observed growing T2DM.* Correspondence: sobngwieugene@yahoo.fr
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unless otherwise stated.Persistent organic pollutants (POPs), one of the classes
of environmental contaminants are a variety of chemi-
cals which are either man-made or accidentally pro-
duced in industrial processes. The groups of compounds
that make up POPs are also classed as PBTs (Persistent,
Bio-accumulative and Toxic) or TOMPs (Toxic Organic
Micro Pollutants). POPs are organic compounds that are
resistant to environmental degradation through chem-
ical, biological, and photolytic processes which enable
them to persist in the environment, to be capable of
long-range transport, bio accumulate in human and ani-
mal tissue, bio accumulate in food chains, and to have
potential significant impacts on human health and the
environment. POPs are generally classified into five main
types which include polychloro-dibenzopara dioxins
(PCDD) and polychloro-dibenzo furans (PCBF), poly-
chlorinated biphenyls (PCBs), organo-chlorine (OC) pes-
ticides, and poly-brominated flame retardants. The first
three are also known as organo-chlorine compounds.
Organo-chlorine compounds were banned in the late
1970s because of their toxicity. Lipid solubility, persistence
in the environment and bioaccumulation potential in tis-
sues through the food chain made these compounds to beThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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logenated structure of the POPs. Human exposure to
POPs occurs primarily through the consumption of ani-
mal fats like fatty fish, meat and dairy products [2]. There
are geographic and socio-economic variations in type and
route of exposure. Low and middle income countries
population are at higher risk of exposure to POPs, either
acute to high concentrations or chronic as long-term ex-
posure to lower concentrations through diet, agriculture,
occupation, and accidents especially for substances re-
stricted or banned in developed countries. One of the
POPs that is highly used in low and medium countries is
dichloro-diphenyltrichloro-ethane (DDT)
DDT is a colourless, crystalline, tasteless and almost
odourless organo-chloride which was initially produced
and used to control malaria and typhus. It was used dur-
ing the Second World War to control malaria and ty-
phus among civilians and troops. After the war, DDT
was made available for use as an agricultural insecticide.
With the discovery of toxicological activity of DDT, its
agricultural use was banned in the United States in
1972. By 1991, total ban on the use of DDT, including in
disease control was implemented in about 26 countries.
Due to the effectiveness of DDT against malaria and the
burden of malaria especially in low and medium income
countries, DDT even though banned is still used till
date. Despite the possible role of DDT in the control of
pest, its use should be avoided due to its negative effect
on human health. It is classified as moderately toxic by
the United States National Toxicology Program. More-
over, a number of studies from the US, Canada and
Sweden have found that the prevalence of diabetes in-
creases with serum DDT level. Several recent studies
demonstrate a link between in-utero exposure to DDT
and its metabolites and developmental neurotoxicity in
humans. DDT has also been shown to induce neurological
problems such as Parkinson’s and Alzheimer’s disease.
A review of the evidence on the association between
organo-chlorine compounds and diabetes was published
in 2005 [3]. However since then, new evidence have
emerged to further substantiate such an association and
putative mechanisms are increasingly tested, justifying
an updated appraisal of existing evidences. Novel reviews
have been published on the association between POPs
and diabetes but limited to epidemiological studies [4,5].
Accordingly we reviewed the evidence from epidemio-
logical and experimental studies on the association be-
tween exposures to persistent organic pollutants and
type 2 diabetes risks. Additionally, we discussed the pos-
sible metabolic derangements and molecular mecha-
nisms underlying such an association. We also explored
evidence that would support the potential for exposure
to POPs during foetal life to contribute to increased risk
at adult age.Methods
The main databases used for the search of articles in-
cluded in this study were PUBMED and HINARI.
PUBMED search used the following key words: Type 2
diabetes + POPs, POPs + insulin resistance, POPs + insu-
lin secretion, review + POPs + Diabetes, POPs + in-utero
+ exposure + diabetes. References from articles relating
POPs to type 2 diabetes were used to search for the ori-
ginal articles through HINARI. Our inclusion criteria for
epidemiological analyses comprised any cross sectional
and prospective study with type 2 diabetes as the out-
come published after 2005. For experimental studies, all
available data on POPs and diabetes related complica-
tions were included. Studies on in-utero exposure to
POPs and diabetes were obtained through the Google
search engine to complement those from PUBMED.
Evidence from epidemiological studies
Evidence prior to 2005
Evidence from epidemiological studies published before
2005 has been summarised previously by Arisawa et al.
in 2005 who included 6 studies confirming an associ-
ation between exposure to persistent organic pollutants
and the risk of type 2 diabetes. These studies of which
one was longitudinal and 5 cross sectional were pub-
lished between 1997 and 2001. The main POPs included
were PCDD, polychlorinated dibenzofuranes (PCDF)
and PCBs, and exposure was mostly accidental in which
individuals used substances containing POPs at work.
They confirmed the association between POPs and type
2 diabetes but could not determine a causal relationship
in the absence of experimental evidence [3].
Post 2005 epidemiological studies
Since the review by Arisawa et al. several other epi-
demiological studies have focused on the association be-
tween exposure to persistent organic pollutants and the
risk of developing type 2 diabetes, using different de-
signs. The characteristic of these studies are summarised
in Tables 1 and 2.
Evidence from cross-sectional and case–control studies
Since 2005, at least 20 cross-sectional studies conducted
in about 12 countries have been published on the associ-
ation of POPs with diabetes risk. The number of partici-
pants across studies ranged from 65 to 2047, the
proportion of men from 30.0% to 64.3% and the propor-
tion with diabetes from 5.8% to 27.4%. Even though with
a diabetes prevalence of 11%, the number of diabetes
cases was the least (2) in the study of [6]. The associ-
ation between POPs and diabetes was based on compar-
ing the mean value of POPs in diabetic and non diabetic
individuals. Diagnosis of diabetes varied across studies
and was based on FPG ≥126 mg/dl, non-fasting glucose
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Table 1 Cross sectional studies of the association of POP with diabetes risk (Continued)
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taking prescribed glucose-lowering medication, non-
diagnosed participants with plasma HbA1c >6.1%, 2-h
plasma glucose ≥ 199.8 mg/dL, and HbA1c level ≥6.9%.
Over 58 POPs compound were investigated in those
studies with a minimum of two and a maximum of 36
per study. Measures of associations used to assess the ef-
fect of these compounds on diabetes risk across studies
included differences in the prevalence of diabetes
amongst groups, odd ratios which were often adjusted
for common diabetes risk factors like age, sex, body
mass index, race/ethnicity, alcohol use, smoking, high
blood (BP) pressure or BP indices, lipids, medication use
and waist circumference. Exposure was expressed as cat-
egorized variables ranging from two groups to quintiles
with the group having low plasma POP constituting the
control group. The odd ratio in the fifth quintile com-
pared to the reference group ranged from 1.9 for PBDE-
153 Lim et al. [7]) to 37.7 [8]. Stratification in tertiles
gave an OR of 3.9 (95% confidence interval, 1.5–10.6)
for total PCBs [9]. PCB-153,pp’-DDT, and pp’-DDE were
associated with type 2 diabetes in all studies while non di-
oxin like PCBs, HCB, BDE-47, BDE-153 and HCH were
associated with diabetes only in one study (Table 1).
Evidence from longitudinal and time-series studies
Since 2005, at least 7 longitudinal studies were published
from about 3 countries reporting on the association of
POPs with diabetes risk. The number of participants
across studies ranged from 180 to 3049. The proportion
of men ranged from 38.4% to 59.2% and the proportion
of participants with diabetes from 4.4% to 19.3%. Two
studies were considered to be case control since the
prevalence of diabetes was very high compared to that of
the normal population. The prevalence was 50% in both
studies [10,11]. In the study conducted by Rignell-
hydbom et al., [10], the controls were randomly selected
from the same cohort with the cases (Women's Health
In the Lund Area cohort) and matched for age, calendar
year, BMI and presence or absence of metabolic syn-
drome at baseline. The second study also included all
participants from the same cohort whereby participants
who developed diabetes during the follow-up were con-
sidered cases and those who were diabetes free were
taken as controls. Diagnosis of diabetes varied across
studies and was based on self-reported physician-
diagnosed diabetes, baseline OGTT, taking glucose-
lowering medications, fasting blood glucose ≥111.6 mg/dL
(≥6.2 mmol/L) non-diagnosed participants with HbA1c
>6.1% (or >6.3%), verified history of diabetes by medical
diagnosis, 2-hour postprandial glucose ≥200 mg/dL, or
fasting 5 glucose ≥126 mg/dL. Over 51 POPs compound
were tested in those studies with a minimum of two and a
maximum of 46 compounds per study. The duration offollow-up in studies varied between 5 and 25 years (mean
= 13.2). Measures of associations used to assess the effect
of these compounds on diabetes risk across studies in-
cluded differences in the incidence of diabetes amongst
groups, odd ratios, least squares geometric means, hazard
ratios, incidence density ratios (IDRs), and relative risk
which were often adjusted for common diabetes risk
factors like age, body mass index, cigarette smoking,
country of birth, education, alcohol intake, hormone,
physical activity, race, lipids and family history of diabetes.
Hexachloro benzene (HCB), 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) and 2,2′-bis(4-chlorophenyl)-1,1-dichlor-
oethylene (pp’-DDE) were associated with the risk of type
2 diabetes while the association was found only in women
when PCBs were investigated. pentabromodiphenylethers
(PBDEs), 2,2',4,4'-tetrabromodiphenyl ether (BDE-47),
dichloro-diphenyl-trichloro-ethane (DDT) and non-
dioxin like PCB were associated with the risk of diabetes
in none of the studies (Table 2).
In all the longitudinal studies included in this review,
bio-monitoring was performed from baseline until the
end of the study. This is shown by the fact that all par-
ticipants included were diabetes free at baseline and only
developed diabetes during the follow-up and participants
with diabetes before baseline were excluded from the
study. Bio-monitoring of POPs was carried out only in
one of the seven studies because exposure was acciden-
tal. Exposure in the other studies was background and
follow up was carried out to determine incident diabetes
cases ([11,12]; Lee et al., [13,14]; Vasiliu et al., [15];
RignellHydbom et al., [10]). In the study conducted by
RignellHydbon et al., [10] blood samples were stored for
at least three years at −70°C before POPs analysis. Ana-
lysis of POPs was performed at the end of follow-up.
Other studies analyzed POPs at enrolment with blood
samples store at −20°C or −70°C (Lee et al., [16]; Micha-
lek and Pavuk., [12,14,17]). Moreover, analysis of POPs
was performed once throughout the follow-up in most
of the studies ([11]; Lee et al., [14,16]; Vasiliu et al., [15];
RignellHydbon et al., [10]). Even though multiple ana-
lyses of POPs was carried out by [17], only one point
measurement was used in the analysis since veterans
who participated in at least one of the last five examina-
tions were included in the study. Reverse causality can
be a possible association between type 2 diabetes and
POPs where individuals with diabetes are unable to me-
tabolise POPs resulting to a higher concentration com-
pared to non diabeteic individuals. This can be evaluated
in studies with repeated measurements POPs [12].
Limitations and strengths of the available epidemiological
studies
Several epidemiological studies have evaluated the asso-
ciation between POPs and diabetes using accidental
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organo-chlorine (OC) pollutants [19]. These exposure
rates are higher than those observed in the general
population. Therefore, results from these studies can
only evaluate the health risk of persistent organic pollut-
ants but cannot be generalised in the total population
more often affected by chronic low concentration expos-
ure. Moreover most of the studies with background ex-
posure to polychlorinated biphenyls (PCBs) and
organochlorine pesticides ([9,20,21]; Lee et al. [22-25])
had a cross sectional design. As such, a causal relation-
ship cannot be established considering for instance the
possibility that diabetic individuals may have a reduced
capacity to excrete or metabolise pollutants leading to a
high concentration of POPs in diabetic individuals com-
pared to those without. In-depth investigation of the ef-
fect of chemicals on the processes leading to the
development of diabetes is thus required. The small
sample size and prevalence of diabetes in some studies
reduced to unstable estimates of the association. More-
over, Michalek and Pavuk did not observe any difference
in diabetes prevalence between the exposed and the un-
exposed groups [17]. The study was aimed at assessing
the association between 2,3,7,8-tetrachlorodibenzo-p-di-
oxin (TCDD) and diabetes and TCDD and cancer in vet-
erans involved in the spraying of Agent Orange and
other TCDD contaminated herbicides in Vietnam from
1962 to 1971. Two groups were involved in the study;
one responsible for the spraying of Agent Orange and a
comparing group a cohort of other Air Force veterans
who served in the Southeast Asia (SEA) region during
the same period that the Ranch Hand unit was active
but who did not spray herbicides. The test group was ex-
posed to Agent Orange contaminated with TCDD dur-
ing the Vietnam War. Despite the lack of association
between the two groups, stratification by calendar period
of service and days of spraying revealed a significant in-
crease in the risk of diabetes among Ranch Hands who
served during or before 1969 and who had at least
90 days of spraying [17]. This study suggested that the
risk of type 2 diabetes might be associated with the dur-
ation of exposure which can better be evaluated in longi-
tudinal studies
Longitudinal studies have been carried out to establish
a causal relationship between type 2 diabetes and POPs
(Vasiliu et al. [15], Rignell-Hydbom et al. [10-12], Lee
et al., [14,16]) although exposure rates were higher than
those observed in the general population. However, a
study carried out among general inhabitants in Japan
confirmed a high risk of diabetes in individuals with high
level of Dioxin [26]. The most convincing evidence for a
relationship between diabetes and persistent organic pol-
lutants (POPs) in humans comes from accidental or oc-
cupational exposures to high levels of these compounds.This is documented by David O Carpenter in a review
entitled "Environmental Contaminants as Risk Factors
for Developing Diabetes". The studies carried out in in-
dividuals occupationally exposed to high level of this
class of POPs showed an increase in the prevalence and
incidence of diabetes compared to the general popula-
tion. There was a significantly elevated deaths from dia-
betes among women exposed to dioxins at Seveso, Italy
living in the zone with intermediate exposure (OR = 1.9,
95% CI: 1.1-3.2) [27]. Analysis of data reported from 36
international cohorts of workers in phenoxyacid herbi-
cide and chloro-phenol plants, where dioxins were an
un-intended by product reported a RR of 2.25 (95% CI:
0.53-9.50) for diabetes in these workers [28]. Moreover,
60% of workers in two US chemical plants had diabetes
and workers with the highest extrapolated TCDD con-
centrations had a significantly increased mean serum
glucose concentration [29]. All these studies substantiate
the fact that high exposure to POPs from occupational
and accidental setting increases the risk of type 2
diabetes.
Epidemiological associations between persistent or-
ganic pollutants and type 2 diabetes have been widely
assessed in Europe, Asia and America. However, the
intentional use has been restricted or banned in many
developed countries. Studies on the association between
these contaminants and diabetes in developing countries
particularly Africa are lacking while the prevalence of
diabetes is predicted to increase the highest in the re-
gion. Some studies [12,20,21,23,30] used only self-
reported physician-diagnosed diabetes as a diagnostic
criteria for diabetes. A false diagnosis will modify the
prevalence or incidence rate and in turn dilute estimates
of the association. Moreover, differences in the diagnosis
criteria make it impossible to compare the magnitude of
the association across studies.
Metabolic derangements associated with exposure to
POP
Insulin resistance and defects in insulin secretion have
been investigated in in-vitro and in-vivo experimental
studies, as the possible metabolic derangements linking
exposure to POPs and diabetes occurrence. Insulin plays
a fundamental role in the uptake of glucose by the adi-
pose tissue, liver and muscles. Insulin exerts its action
by binding to its receptor and initiating a cascade of re-
actions culminating with the translocation of the glucose
transporter from the endoplasmic reticulum to the
plasma membrane for glucose uptake. Competition be-
tween insulin and other ligands for the receptor as well
as modulation of the expression of genes involved in the
signaling cascade will lead to an insulin resistance state.
The overproduction of insulin by the pancreatic beta cell
to compensate for the insulin resistance state might lead
Ngwa et al. Diabetology & Metabolic Syndrome  (2015) 7:41 Page 11 of 15to the exhaustion of the cells and future type 2 diabetes.
POPs have been shown to affect these pathways both in
human and animal studies.
Human studies: effect of POPs on insulin secretion and
insulin resistance
Few studies in human subjects have reported that POPs
increases the risk of insulin resistance both in diabetic
and non-diabetic individuals [13,22,31,32]. In a study
carried out in non-diabetic individuals with background
exposure to TCDD, it was observed that individuals with
level of TCDD greater than 15 ppb had high fasting and
pros-prandial insulin levels after a glucose load com-
pared to individuals with low level TCDD, suggesting
that high blood TCDD may cause insulin resistance [31].
Another study focusing on low dose exposure to
organo-chlorine (OC) pesticides and PCBs observed a
non monotonic dose response (U shape) association
between POPs and insulin resistance in non-diabetic in-
dividuals [16]. Toxicity is assumed to be directly propor-
tional to the dose of the chemical. However, some
substances especially endocrine disruptors may cause
biological response at doses well below those levels pre-
viously tested and determined to be safe. A U-shape
curve is therefore obtained between exposure and out-
come when low exposure corresponding to high bio-
logical effect is considered to be the control group.
However other studies have not found an association be-
tween POPs and insulin resistance defined by HOMA-IR
[6,33]. Some have suggested an effect of POPs on insulin
secretion instead of insulin resistance [33].We found
only one published study exists on the association be-
tween POPs and insulin secretion in human subjects.
Jørgensen and collaborators observed a significant nega-
tive association between POPs and indices of insulin se-
cretion: stimulated insulin and HOMA-B indicating that
POPs may affect basal and stimulated insulin secretion
[33]. Studies with accurate measurement of insulin se-
cretion and insulin action are warranted. In fact, few in-
vestigations used clamp studies or other dynamic
testing. Two studies have evaluated the association be-
tween POPs and insulin action using euglycemic hyper-
insulinaemic clamp as a measure of insulin action.
Færch et al. used two different clamp procedures. In one
study group, a euglycemic-hyperinsulinemic clamp at
40 mU/m2.min for 4 h was performed after a 2-h basal
period. In the second group, the 2-h basal period was
followed by a 30-min IVGTT for assessment of first-
phase insulin secretion [34]. Immediately after the
IVGTT, a euglycemic-hyperinsulinemic clamp at
40 mU/m2.min for 2 h was performed. In their study,
individuals with prediabetes and diabetes had higher
serum concentrations of several POPs (HCB, p,p’-
DDE, p,p’-DDT, PCB-118 and PCB-156) comparedwith normoglycemic individuals. Moreover, in the non-
diabetic population, higher POPs levels were associ-
ated with elevated fasting plasma glucose concentra-
tions as well as reduced glucose oxidation, elevated
lipid oxidation, and elevated serum concentrations of
free fatty acids. However, after exclusion of diabetic pa-
tients, there were no differences between the two study
populations with regard to fasting plasma glucose,
serum insulin, HOMA-IR, or HOMA-B [34]. Gauthier
et al. in their study measure insulin sensitivity using
the 3-hour hyperinsulinemic-euglycemic clamp as de-
scribed by Defronzo [35]. Despite the fact that an asso-
ciation between POPs and insulin resistance was not
evaluated in this study, it could be deduced from the re-
sults that insulin sensitivity characterized by 3-hour
hyperinsulinemic-euglycemic clamp was inversely as-
sociated with the concentration of POPs. This is be-
cause insulin sensitivity was higher in metabolically
healthy but obese 8 individuals who had a lower con-
centration of POPs compared to metabolically abnor-
mal obese individuals with a higher concentration of
POPs [36].Animal studies: effect of POPs on insulin secretion and
insulin resistance
The effects of POPs on insulin secretion and insulin re-
sistance have been evaluated in few animal studies. The
first animal study to observe an effect of POPs on insu-
lin resistance was carried out in Sprague–Dawley rats
[37]. These rats were exposed for 28 days to lipopholic
POPs through the consumption of high fat diet contain-
ing either refined or crude fish oil obtained from farmed
Atlantic salmon. Insulin sensitivity was assessed in the
soleus muscle and epididymal fat using the hyper-
insulinemic-euglycemic clamp technique. Furthermore,
cultured and differentiated 3 T3-L1 cells were used to
assess insulin-stimulated glucose uptake in-vitro. There
was a significant inhibition of insulin-dependent glucose
uptake in skeletal muscle of animals fed on high fat diet
containing POPs (in-vivo) as well as differentiated adipo-
cytes treated with nano-molar concentrations of POP
(in-vitro) [37]. Moreover, C57BL/6 J mice fed a very
high-fat (VHF) diet containing farmed Atlantic salmon
fillet (a source of POPs) for 8 weeks when compared
with another group of very high fat diet without
POPs or chow diet, had a significant high fasting and
pros-prandial glucose level [38].There was also a re-
duced response to glucose clearance following insulin
load relative to VHF- and Chow-fed mice all, features
demonstrating a state of insulin resistance [38].Ad-
ministration of PCB-77 or PCB-126 has also been
shown to impair glucose homeostasis in lean mice and in
obese mice [39].
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Amongst the different classes of persistent organic pollut-
ants (POPs), 2,3,7,8-tetrachlo-rodibenzo-p-dioxin (TCDD)
has been extensively studied and the possible mechanism
of disruption of beta cell function reviewed [40]. One
prominent symptom of acute toxicity from TCDD is a loss
of adipose tissue and body weight, a phenomenon known
as the wasting syndrome [41]. This syndrome is charac-
terised by hypophagia, hyper-lipidaemia and hyper-
triglyceridaemia suggesting that affected animals are un-
able to utilize the energy-rich nutritional compounds
available in their blood. The main pathway of TCDD ac-
tion is through the aryl hydrocarbon receptor. Binding of
TCDD to aryl hydrocarbon receptor causes changes in
translational and transcriptional mechanisms resulting in
diminished GLUT expression (Enan et al., [42]). Inhibition
of GLUT translocation from the cytoplasm to the plasma
membrane as well as reduced glucose transporter avail-
ability limits the uptake of glucose which is a hallmark of
insulin resistance. A decrease in the level of mRNA of the
glucose transporter (GLUT) gene and protein levels as
well as the glucose uptake was observed in TCDD treated
P19 cells [43]. Moreover, treatment of 3 T3-L1 adipocytes
with 10nM TCDD caused decreases in the expression
levels of insulin 9 receptor beta (IRβ), insulin receptor
substrate 1 (IRS1) and GLUT4 and insulin-stimulated glu-
cose uptake activity, strongly suggesting that TCDD trig-
gers dysfunction of the insulin signalling pathway in
adipocytes [44]. Even low doses of TCDD (0.03 pg/kg)
causes a significant reduction in the glucose transporting
activity of guinea pig adipose tissue and pancreas [45].
Compared with TCDD, the effects of polychlorinated bi-
phenyls (PCBs) on insulin secretion are less thoroughly
studied. However, a more recent study investigated the in-
vitro and in-vivo effects of coplanar PCBs on adipose ex-
pression of tumour necrosis factor α (TNF-α) and on glu-
cose and insulin homeostasis in lean and obese mice [39].
In cultured adipocytes, PCB-77 promoted TNF-α expres-
sion through an AhR-dependent mechanism suggesting
that PCBs could promote insulin resistance through
adipose-specific increases in TNF-α [39].
Maintenance of blood glucose homeostasis by the
endocrine system involves a series of complex gene-
environment interactions between different tissues, in-
cluding the liver, skeletal muscle, adipose tissue, brain
and the pancreas. Altered glucose homeostasis leads to
type 2 diabetes, which consists of defects in both insu-
lin secretion and insulin action (insulin resistance)
[46]. Since the beta cells of the pancreas are central to
controlling glucose homeostasis, an endocrine disrupting
chemical that can initiate, facilitate and/or accelerate the
loss of beta cell function can play an important role in
type 2 diabetes. Moreover, obesity the main predictor oftype 2 diabetes is a complex endocrine-related disease
caused by the interaction between genetic, behavioral, and
environmental factors [47]. Therefore endocrine disrup-
tion could be the possible link between obesity and dia-
betes. Moreover, POPs have also been shown to possess
endocrine disruption activities through interaction with
estrogen receptors [48] and peroxisome proliferator recep-
tor (PPAR) receptor [49]. Endocrine disruptors are chemi-
cals that, at certain doses, alter the normal functioning of
hormones and other signaling molecules in the body. The
endocrine disrupting activities of these POPs include their
effects on thyroid hormone. Thyroid hormone is essential
for normal brain development, for the control of metabol-
ism, and for many aspects of normal adult physiology.
Therefore, changes in the functions of the thyroid gland
or interference with the ability of thyroid hormones to
exert their actions may produce effects on development,
metabolism, or adult physiology. POPs interfere with the
thyroid function by acting on different points of regulation
of thyroid hormones synthesis, release, transport through
the blood, metabolism of thyroid hormones, and thyroid
hormones clearance [50]. The best example is PCB which
can reduce circulating levels of thyroxine (T4) in animals
(Bastomsky., [51,52]).
In-utero exposure to POPs and diabetes risk
In-utero exposure to several factors including persistent
organic pollutants (POPs) has been shown to increase
the risk of many diseases. In pregnant women, POPs
have been shown to cross the placenta [53]. The devel-
opmental origin of health postulates that adverse foetal
exposure may lead to permanent foetal adaptations in
structure, physiology and metabolism. These adaptations
might be beneficial for short term foetal survival, but
may lead to foetal growth retardation, cardiovascular
and metabolic diseases in adulthood. The association be-
tween intrauterine exposure to persistent organic pollut-
ants and birth weight has been highly investigated.
However findings from these studies are inconsistent
and the association has been reviewed by Govarts et al.
[54]. In the meta-analysis consisting of European birth
cohorts they observed that decrease in birth weight in-
dependently of gestational age was associated with in-
creasing foetal PCB-153 concentrations. [54]. Across all
cohorts birth weight declined by 150 g for each 1-μg/L
increase of PCB-153 in cord serum. However, no associ-
ation was observed with the DDT metabolite p,p´-DDE.
Due to inconsistent results in previous studies, other stud-
ies (summarised in Table 3) have been carried out to
examine the nature of the association. It was observed that
higher concentrations of PBDEs in maternal serum during
pregnancy were associated with lower birth weight in a
population of low-income women living in California
[55]. Moreover a 10-fold increase in concentrations of





Compound used Direction of the
association
Confounders




Background CB-153 and p,p’ -DDE Negative Maternal age, pre-pregnancy BMI, education, marital status,
smoking status, alcohol drinking, parity and newborn’s sex
[55] 286
women
Background PBDEs Negative Maternal age, education, marital status, parity, BMI, country
of birth, alcohol and drug use during pregnancy and
infant sex
[57] 494 Background DDT, DDE, HCB and
PCBs
Negative Age, height, pregnancy weight gain, pre-pregnancy BMI,
country of origin, residence, parity, education, employment
during pregnancy, socioeconomic status
[68] 247
children
Occupational Not stated Negative Maternal smoking, social class and gestational age
[59] 503
women
Background Not stated No association Race, education, age, gestational age at delivery and
Child’s sex
[58] 413 Background PCBs and PBDEs Positive with PCB and
negative with PBDEs
Maternal age, pre-pregnancy BMI, weight gain during
pregnancy, education, smoking during pregnancy and sex
of the child
[69] 325 Not stated 14 OC pesticides, 7
PCBs and 14 PBDEs
Negative Age, pre-pregnancy BMI, educational level, and fish
consumption
Organochlorine (OC) pesticides, polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs), 2,2,4,4,5,5-hexachlorobiphenyl (CB-153), 2,
2′-bis(4-chlorophenyl)-1,1-dichloroethylene (p,p′-DDE), di-chlorodiphenyl-trichloro-ethane (DDT), hexachlorobenzene (HCB), body mass index (BMI).
Ngwa et al. Diabetology & Metabolic Syndrome  (2015) 7:41 Page 13 of 15BDE-47,-99, and −100 was associated with an approxi-
mately 115-g decrease in birth weight. Another study
found a significant reduction in birth weight and length
of gestation associated with maternal CB-153 exposure
among Inuits but not in the Kharkiv or War-saw co-
horts [56]. A cohort study from Valencia revealed that
prenatal exposure to OCs may exert adverse health ef-
fects on birth size, reducing the birth weight, length,
and head circumference as shown by a significant de-
crease of 63 and 107 g in birth weight with each 10-fold
increase in cord serum 4,4’-DDT and 4,4’-DDE concen-
trations, respectively [57]. A more recent study found a
weak but significant positive association between back-
ground prenatal exposure to di-ortho PCBs and birth
weight [58]. However, others studies showed that intra-
uterine exposure to some persistent organic pollutants
was not associated with birth weight [59]. A large number
of published studies have also reported negative associa-
tions between in-utero exposure to persistent organic pol-
lutants and birth weight ([54], Table 3). A nested case
control study carried out by Rignell-Hydbom and collabo-
rators showed that POPs were not associated with type 1
diabetes [60]. Moreover, we found no published study on
the association between in-utero exposures to POPs and
type 2 diabetes risks. Inconsistency results across studies
can be explained by the following reasons: some studies
evaluated the association in background exposure while
others used accidental or occupational settings. Moreover,
the studies used different sampled sizes and evaluated dif-
ferent POPs. Nevertheless, a risk of type 2 diabetes can beattributed to intrauterine exposure to POPs because of the
three way association diabetes, POPs and obesity. There-
fore, we can speculate that low birth weight increases the
risk of diabetes in adulthood either as a result of under
nutrition, through exposure to POPs or both.Conclusion
Type 2 diabetes is increasing at alarming rates in both
developed and developing countries. Cross-sectional
epidemiological studies have established an association
between POPs and type 2 diabetes. Despite different
levels of risk in prospective studies and inconsistent re-
sults, the causal effect of POPs on diabetes is supported
by in-vitro and in-vivo experimental studies. However,
detailed mechanistic information on how these pollut-
ants interfere with insulin metabolism is lacking. Fur-
thermore, experimental studies have focused more on
the effect of POPs on insulin resistance. Therefore,
more research efforts are needed on the interaction of
compounds with beta-cell function and/or mass in
animal models at human relevant concentrations to
further evaluate the hypothesis that environmental pol-
lutants can be additional risk factors for diabetes devel-
opment. These studies should focus on both peri-natal
and in-utero exposure which is thought to affect gene
expression through epigenetic mechanisms. Simultan-
eously epidemiological studies focusing on low level
background exposure should be carried out in the gen-
eral population.
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